Recruiting
Phase 2

Convalescent Plasma as a Possible Treatment for COVID-19

Sponsor:

University of Illinois at Chicago

Code:

NCT04442191

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Convalescent plasma

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information